← Patec Precision Industry overview

Patec Precision Industry vs Yushu Technology: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Patec Precision Industry Co Ltd (2236.TW)

Yushu Technology (688836.CG)

Q3 2026
▲2▼1

Unitree IPO soars, but US ban and cheap robots temper gains

  • STAR Market IPO and debut surge China approved Unitree's STAR Market IPO, raising about $904 million with backing from DeepSeek and Tencent. The stock surged 460-600% on debut, valuing the company near $50 billion.

    This was the quarter's biggest positive event, directly boosting the stock price.

  • Strong shipment growth and new products Unitree shipped 5,900 humanoid robots and unveiled new products. Shipments are expected to double, showing growing demand for its robots.

    Operational growth supports revenue prospects and investor optimism.

  • US ban on Chinese robots The US banned Chinese humanoid and quadruped robots, cutting off a market worth about 13% of Unitree's overseas revenue. Unitree also remains on the Pentagon's military-company list, adding reputational risk.

    This regulatory action directly threatens revenue and reputation, acting as a counterweight.

  • Tighter IPO rules and cheap robot mix China tightened IPO rules for humanoid startups, potentially cooling the sector. Also, most shipments are smaller, cheaper robots, so headline growth may overstate real industrial adoption.

    These factors could limit future growth and temper the positive shipment narrative.

September 2026
▲2▼2

Unitree's IPO, US robot ban, and new listing rules reshape the story

  • IPO priced and listed, raising billions Unitree set its IPO price at 150.80 yuan, raised about 6.1 billion yuan, and listed on Shanghai's STAR Market on Aug. 19. The stock jumped over 460% on its first day. This gives the company fresh cash to grow and puts it in the public eye, which supports the share price.

    The IPO is the single biggest new event for the company this period, directly affecting its capital and market profile.

  • US bans Chinese humanoid robot imports The US FCC banned imports of foreign-made humanoid robots, clearly aimed at Chinese makers like Unitree, and the US also put tariffs of up to 100% on drones. This shuts Unitree out of the US market for now, a real headwind for future sales growth.

    This is a new regulatory barrier that directly limits Unitree's access to a major market.

  • China tightens rules for humanoid robot IPOs After Unitree's fast-track listing, China's securities regulator set three strict criteria for humanoid robot startups to go public: real revenue and orders, narrowing losses, and core technology. Few startups may qualify, which could slow the whole sector's access to public money and cool investor enthusiasm.

    New regulation triggered by Unitree's own listing could make it harder for the sector to raise capital, affecting sentiment and future competition.

  • Shipments doubling, but mostly small robots BTIG estimates Unitree built about 31,000 humanoids by June and expects 2026 shipments to at least double from around 6,000 in 2025, with plans for 30,000 units a year. However, most shipments are smaller, cheaper robots, not full-size industrial workers, so the headline growth may overstate real adoption.

    This gives a clear demand picture: strong unit growth but concentrated in lower-priced products, which matters for revenue quality.

Latest
▲2▼2

Unitree's IPO, US robot ban, and new listing rules reshape the story

  • IPO priced and listed, raising billions Unitree set its IPO price at 150.80 yuan, raised about 6.1 billion yuan, and listed on Shanghai's STAR Market on Aug. 19. The stock jumped over 460% on its first day. This gives the company fresh cash to grow and puts it in the public eye, which supports the share price.

    The IPO is the single biggest new event for the company this period, directly affecting its capital and market profile.

  • US bans Chinese humanoid robot imports The US FCC banned imports of foreign-made humanoid robots, clearly aimed at Chinese makers like Unitree, and the US also put tariffs of up to 100% on drones. This shuts Unitree out of the US market for now, a real headwind for future sales growth.

    This is a new regulatory barrier that directly limits Unitree's access to a major market.

  • China tightens rules for humanoid robot IPOs After Unitree's fast-track listing, China's securities regulator set three strict criteria for humanoid robot startups to go public: real revenue and orders, narrowing losses, and core technology. Few startups may qualify, which could slow the whole sector's access to public money and cool investor enthusiasm.

    New regulation triggered by Unitree's own listing could make it harder for the sector to raise capital, affecting sentiment and future competition.

  • Shipments doubling, but mostly small robots BTIG estimates Unitree built about 31,000 humanoids by June and expects 2026 shipments to at least double from around 6,000 in 2025, with plans for 30,000 units a year. However, most shipments are smaller, cheaper robots, not full-size industrial workers, so the headline growth may overstate real adoption.

    This gives a clear demand picture: strong unit growth but concentrated in lower-priced products, which matters for revenue quality.

August 2026
▲3▼1

Unitree's blockbuster IPO and product news offset by US ban and cost concerns

  • IPO raises $904M with DeepSeek and Tencent backing Unitree's IPO priced at 150.80 yuan, raising about $904 million. DeepSeek and Tencent invested and will jointly develop robot AI, giving the company fresh cash and powerful partners to scale up.

    This is the month's biggest positive event, providing capital and strategic backing that directly boosts growth prospects.

  • Stock surges ~600% on debut, valuing company near $50B The stock skyrocketed about 600% on its first trading day, pushing the company's value to nearly $50 billion. Massive investor demand and oversubscription reflect huge enthusiasm for the humanoid robot leader.

    This is the most direct driver of the stock's price during the period, showing extreme market optimism.

  • Unitree ships 5,900 humanoid units, unveils 'Superman' robot Unitree shipped 5,900 humanoid robots, part of China's 97% share of global deliveries. It also unveiled its 'Superman' robot at the World Robot Conference, and Hangzhou's pilot base supports commercialization.

    These operational milestones demonstrate real progress in production and commercialization, reinforcing the growth story.

  • US FCC bans Chinese humanoid robot imports, blocking key revenue The US FCC banned imports of Chinese humanoid robots, cutting off a market worth about 13% of Unitree's overseas revenue. This adds a real headwind to international expansion.

    This is a new regulatory blow that directly limits Unitree's addressable market and could weigh on future sales.

▲3▼1

Unitree's blockbuster Shanghai debut and record demand drive the stock

  • Record IPO demand and 600% debut surge Unitree's IPO was oversubscribed thousands of times by retail and institutional investors, and the stock surged about 600% on its first trading day, valuing the company at roughly $50 billion. This massive demand directly lifts the share price and gives the company fresh cash to grow.

    This is the single biggest new event of the period and the main reason the stock is moving now.

  • Dominant market share in global humanoid robot deliveries Chinese makers captured over 97% of global humanoid robot deliveries in the first half of 2026, with Unitree shipping 5,900 units. This shows strong real-world demand for its robots and reinforces its leadership, supporting the stock price.

    It provides concrete evidence of Unitree's strong sales and market position, which underpins investor enthusiasm.

  • New Superman robot and World Robot Conference spotlight Unitree unveiled a new high-speed robot called Superman just before its IPO and showcased at the World Robot Conference. The attention boosts its brand and investor interest, helping the stock.

    It highlights ongoing product innovation and publicity that keep investor excitement high.

  • US ban and high robot costs cloud commercial outlook The US ban on Chinese robots blocks a market that was about 13% of Unitree's overseas revenue. Also, humanoid robots cost 300,000-500,000 yuan, far above the 160,000 yuan needed to pay back in two years, raising doubts about mass adoption.

    It is the main counterweight: a real headwind that could limit future growth and temper the stock's rise.

▲3▼1

Unitree IPO prices at 150.80 yuan, raising $904M with DeepSeek and Tencent backing

  • IPO priced at 150.80 yuan, raising 6.1 billion yuan Unitree set its IPO price at 150.80 yuan per share, raising about 6.1 billion yuan (roughly $904 million). This gives the company fresh cash to develop AI models, build more robots, and expand production, strengthening its position as the first humanoid robot maker on mainland China's stock market.

    The IPO pricing is the central new event that directly determines the company's valuation and future funding.

  • DeepSeek and Tencent join as strategic investors AI startup DeepSeek invested $20.8 million and Tencent also joined Unitree's IPO as strategic investors. DeepSeek and Unitree will jointly develop AI models for humanoid robots, combining DeepSeek's AI expertise with Unitree's mechanical engineering. This partnership could speed up the development of smarter robots.

    The involvement of major tech names validates Unitree's technology and adds strategic value beyond just money.

  • Hangzhou pilot base supports productization and commercialization Unitree is a cornerstone partner and 10% shareholder in Hangzhou's national embodied intelligence pilot base, which helps robots move from prototype to real-world products. The base provides testing, training data, and risk-sharing, addressing key commercialization hurdles. This support could accelerate Unitree's path to mass adoption.

    This shows concrete government-backed infrastructure helping Unitree commercialize its robots, a key step for future revenue.

  • US FCC bans imports of Chinese humanoid robots The US FCC banned imports of humanoid and quadruped robots from China, citing national security. This directly blocks Unitree's robots from the US market, cutting off a major potential sales channel. China warned of possible retaliation, but the ban remains a real headwind for Unitree's international growth.

    This is a new US regulatory action that directly limits Unitree's access to a large market, a clear negative force.

July 2026
▲2▼2

Unitree IPO approved, but US ban blocks its robots

  • China approves Unitree's STAR Market IPO The CSRC approved Unitree's IPO registration, letting it raise 4.2 billion yuan for robot R&D and manufacturing. This gives the company fresh cash to scale up production and strengthens its position as China's leading humanoid robot maker, supporting the stock.

    This is the single biggest new event for 688836.CG, directly affecting its capital and growth prospects.

  • New product debut and industry momentum Unitree unveiled its GD01 mecha and hosted a robot street-fighting championship, showing technical progress. Tesla also started installing its Optimus production line. These signal the humanoid robot industry is moving from concept to mass production, which lifts sentiment for Unitree and its suppliers.

    New product and industry milestones reinforce the growth story behind the stock.

  • US bans new Chinese robots, hitting Unitree The Trump administration banned new Chinese-made humanoid and quadruped robots from the US market, citing security risks. This directly blocks Unitree's robots from entering the US, cutting off a major potential sales market and creating a real headwind for the stock.

    This is a direct regulatory blow to Unitree's US sales and a key counterweight to the positive news.

  • Pentagon military-company label adds reputational risk Unitree remains on the Pentagon's list of Chinese military companies, which bars it from US defense contracts and carries reputational harm. Alibaba is suing to get off the same list, highlighting the ongoing risk. This label could deter some international partners and investors.

    The military label is a persistent regulatory and reputational overhang that affects Unitree's global business.

▲2▼2

Unitree IPO approved, but US ban blocks its robots

  • China approves Unitree's STAR Market IPO The CSRC approved Unitree's IPO registration, letting it raise 4.2 billion yuan for robot R&D and manufacturing. This gives the company fresh cash to scale up production and strengthens its position as China's leading humanoid robot maker, supporting the stock.

    This is the single biggest new event for 688836.CG, directly affecting its capital and growth prospects.

  • New product debut and industry momentum Unitree unveiled its GD01 mecha and hosted a robot street-fighting championship, showing technical progress. Tesla also started installing its Optimus production line. These signal the humanoid robot industry is moving from concept to mass production, which lifts sentiment for Unitree and its suppliers.

    New product and industry milestones reinforce the growth story behind the stock.

  • US bans new Chinese robots, hitting Unitree The Trump administration banned new Chinese-made humanoid and quadruped robots from the US market, citing security risks. This directly blocks Unitree's robots from entering the US, cutting off a major potential sales market and creating a real headwind for the stock.

    This is a direct regulatory blow to Unitree's US sales and a key counterweight to the positive news.

  • Pentagon military-company label adds reputational risk Unitree remains on the Pentagon's list of Chinese military companies, which bars it from US defense contracts and carries reputational harm. Alibaba is suing to get off the same list, highlighting the ongoing risk. This label could deter some international partners and investors.

    The military label is a persistent regulatory and reputational overhang that affects Unitree's global business.